RLMD Annual Shareholders Equity
$85.36 M
-$55.08 M-39.22%
31 December 2023
Summary:
As of January 21, 2025, RLMD annual stockholders equity is $85.36 million, with the most recent change of -$55.08 million (-39.22%) on December 31, 2023. During the last 3 years, it has fallen by -$20.23 million (-19.16%). RLMD annual shareholders equity is now -59.02% below its all-time high of $208.26 million, reached on December 31, 2021.RLMD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLMD Quarterly Shareholders Equity
$47.63 M
-$13.87 M-22.55%
30 September 2024
Summary:
As of January 21, 2025, RLMD quarterly stockholders equity is $47.63 million, with the most recent change of -$13.87 million (-22.55%) on September 30, 2024. Over the past year, it has dropped by -$24.42 million (-33.90%). RLMD quarterly shareholders equity is now -77.36% below its all-time high of $210.40 million, reached on March 31, 2022.RLMD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLMD Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.2% | -33.9% |
| 3 y3 years | -19.2% | -34.5% |
| 5 y5 years | +1021.2% | +696.8% |
RLMD Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.0% | at low | -77.4% | at low |
| 5 y | 5-year | -59.0% | at low | -77.4% | +696.8% |
| alltime | all time | -59.0% | +1648.3% | -77.4% | +329.8% |
Relmada Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $47.63 M(-22.6%) |
| June 2024 | - | $61.49 M(-14.6%) |
| Mar 2024 | - | $72.05 M(-15.6%) |
| Dec 2023 | $85.36 M(-39.2%) | $85.36 M(-15.3%) |
| Sept 2023 | - | $100.73 M(-9.5%) |
| June 2023 | - | $111.34 M(-11.3%) |
| Mar 2023 | - | $125.47 M(-10.7%) |
| Dec 2022 | $140.44 M(-32.6%) | $140.44 M(-15.6%) |
| Sept 2022 | - | $166.34 M(-15.5%) |
| June 2022 | - | $196.85 M(-6.4%) |
| Mar 2022 | - | $210.40 M(+1.0%) |
| Dec 2021 | $208.26 M(+97.3%) | $208.26 M(+186.5%) |
| Sept 2021 | - | $72.69 M(-25.0%) |
| June 2021 | - | $96.85 M(+6.3%) |
| Mar 2021 | - | $91.15 M(-13.7%) |
| Dec 2020 | $105.58 M(-8.7%) | $105.58 M(-13.6%) |
| Sept 2020 | - | $122.21 M(-7.6%) |
| June 2020 | - | $132.23 M(+16.9%) |
| Mar 2020 | - | $113.16 M(+1793.2%) |
| Dec 2019 | $115.68 M(+1419.4%) | - |
| Sept 2019 | - | $5.98 M(-21.5%) |
| June 2019 | $7.61 M | $7.61 M(+1506.5%) |
| Mar 2019 | - | $473.90 K(-67.0%) |
| Dec 2018 | - | $1.43 M(-116.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | -$8.74 M(+58.5%) |
| June 2018 | -$5.51 M(-477.5%) | -$5.51 M(+138.0%) |
| Mar 2018 | - | -$2.32 M(-421.1%) |
| Dec 2017 | - | $721.20 K(-50.8%) |
| Sept 2017 | - | $1.46 M(+0.3%) |
| June 2017 | $1.46 M(-79.3%) | $1.46 M(-47.9%) |
| Mar 2017 | - | $2.80 M(-40.1%) |
| Dec 2016 | - | $4.67 M(-16.1%) |
| Sept 2016 | - | $5.57 M(-20.9%) |
| June 2016 | $7.04 M(-20.1%) | $7.04 M(-31.0%) |
| Mar 2016 | - | $10.20 M(-13.3%) |
| Dec 2015 | - | $11.76 M(-15.0%) |
| Sept 2015 | - | $13.84 M(+57.0%) |
| June 2015 | $8.81 M(-894.4%) | $8.81 M(+253.2%) |
| Mar 2015 | - | $2.49 M(-45.7%) |
| Dec 2014 | - | $4.59 M(-122.2%) |
| Sept 2014 | - | -$20.72 M(>+9900.0%) |
| June 2014 | -$1.11 M(+7994.9%) | - |
| Feb 2014 | - | -$31.20 K(+11.4%) |
| Nov 2013 | - | -$28.00 K(+104.4%) |
| Aug 2013 | -$13.70 K(-220.2%) | -$13.70 K(-35.7%) |
| May 2013 | - | -$21.30 K(+1083.3%) |
| Feb 2013 | - | -$1800.00(-115.8%) |
| Aug 2012 | $11.40 K | $11.40 K |
FAQ
- What is Relmada Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Relmada Therapeutics?
- What is Relmada Therapeutics annual shareholders equity year-on-year change?
- What is Relmada Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly shareholders equity year-on-year change?
What is Relmada Therapeutics annual stockholders equity?
The current annual shareholders equity of RLMD is $85.36 M
What is the all time high annual shareholders equity for Relmada Therapeutics?
Relmada Therapeutics all-time high annual stockholders equity is $208.26 M
What is Relmada Therapeutics annual shareholders equity year-on-year change?
Over the past year, RLMD annual stockholders equity has changed by -$55.08 M (-39.22%)
What is Relmada Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of RLMD is $47.63 M
What is the all time high quarterly shareholders equity for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly stockholders equity is $210.40 M
What is Relmada Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, RLMD quarterly stockholders equity has changed by -$24.42 M (-33.90%)